Andrea Ellis
Director · 1 filing · Latest: Mar 4, 2026
BridgeBio Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BBIO | Andrea Ellis | Director | Mar 4, 2026 | Sale | $64.87 | 64,921 | $4.2M | 18,589 | |
BBIO | Andrea Ellis | Director | Mar 4, 2026 | Option Exercise | $8.45 | 64,921 | $548.6K | 83,510 | |
BBIO | ANDREA ELLIS | — | Mar 4, 2026 | Proposed Sale | $64.87 | 64,921 | $4.2M | — | |
BBIO | ANDREA ELLIS | — | Aug 5, 2025 | Proposed Sale | $49.00 | 17,167 | $841.2K | — | |
BBIO | ANDREA ELLIS | — | Apr 14, 2025 | Proposed Sale | $35.00 | 10,000 | $350.0K | — | |
BBIO | ANDREA ELLIS | — | Apr 1, 2025 | Proposed Sale | $34.05 | 30,000 | $1.0M | — |